These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14839871)

  • 21. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity.
    Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ
    Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
    FILLA E; COMENALE D; ROSSI F
    Minerva Med; 1964 Aug; 55():2417-22. PubMed ID: 14192139
    [No Abstract]   [Full Text] [Related]  

  • 23. [Report on experiences with the new antibiotics Tb I, PAS and streptomycin, alone and in combination, in the treatment of pulmonary tuberculosis].
    BOTTKE H; SCHROTER W
    Tuberkulosearzt; 1950 Oct; 4(10):573-9. PubMed ID: 14788303
    [No Abstract]   [Full Text] [Related]  

  • 24. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 25. [SYMPOSIUM: COUNTER-MEASURES IN INTRACTABLE PULMONARY TUBERCULOSIS].
    KITAMOTO O
    Kekkaku; 1963 Aug; 38():348-71. PubMed ID: 14046681
    [No Abstract]   [Full Text] [Related]  

  • 26. CHEMOTHERAPY OF TUBERCULOSIS.
    HORNE NW
    Biochem Clin; 1964; 4():207-15. PubMed ID: 14268921
    [No Abstract]   [Full Text] [Related]  

  • 27. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
    NOVAK M; JANCIK E
    Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and evaluation of the antibacterial and antitubercular activity of some N1-aral-N4-(3-chloro-4-fluorophenyl)thiosemicarbazones and their copper(I) complexes.
    Khazi IM; Koti RS; Chadha MV; Mahajanshetti CS; Gadad AK
    Arzneimittelforschung; 2005; 55(2):107-13. PubMed ID: 15787278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives.
    Güzel O; Karali N; Salman A
    Bioorg Med Chem; 2008 Oct; 16(19):8976-87. PubMed ID: 18804379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tuberculosis treatment with thiosemicarbazones (TB I and TB VI)].
    RUZICZKA O
    Wien Klin Wochenschr; 1949 Dec; 61(50-51):946. PubMed ID: 15399128
    [No Abstract]   [Full Text] [Related]  

  • 31. Discovery of new antitubercular oxazolyl thiosemicarbazones.
    Sriram D; Yogeeswari P; Thirumurugan R; Pavana RK
    J Med Chem; 2006 Jun; 49(12):3448-50. PubMed ID: 16759086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthetic antitubercular agents. Note 1. Thiosemicarbazones of alpha-thio-(p-aldophenyl) acids and esters].
    TRAVE R
    Farmaco Sci; 1960 Jul; 15():468-73. PubMed ID: 13855106
    [No Abstract]   [Full Text] [Related]  

  • 33. [Synthetic antitubercular agents. Note 2. Thiosemicarbazones of alpha-sulfonyl-(p-aldophenyl) acids and esters].
    TRAVE R
    Farmaco Sci; 1960 Jul; 15():474-82. PubMed ID: 13855107
    [No Abstract]   [Full Text] [Related]  

  • 34. [Curability of grave chronic rheumatic inflammatory joint diseases and of grave psoriasis with metal colloid therapy and simultaneous use of anti-tuberculosis drugs].
    MULLER E
    Praxis; 1952 Dec; 41(51):1112-3. PubMed ID: 13047137
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment with new antitubercular agents].
    Gartmann J
    Dtsch Med Wochenschr; 1968 Nov; 93(47):2281-2. PubMed ID: 4301079
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the antitubercular activity of pyridoxal thiosemicarbazones].
    SAH PP; PENG CT
    Arch Pharm Ber Dtsch Pharm Ges; 1960 May; 293/65():501-5. PubMed ID: 14440779
    [No Abstract]   [Full Text] [Related]  

  • 37. The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone.
    Gopal P; Dick T
    Int J Antimicrob Agents; 2015 Apr; 45(4):430-3. PubMed ID: 25704063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Conservative treatment of renal tuberculosis].
    Strauss I
    Ther Ggw; 1966 Jul; 105(7):872-85. PubMed ID: 5951003
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of low doses of tibon in the antibacterial therapy of pulmonary tuberculosis].
    Murik SO; Granat AI
    Probl Tuberk; 1977 Jun; (6):53-5. PubMed ID: 882563
    [No Abstract]   [Full Text] [Related]  

  • 40. [Galleria mellonella test in the study of the antituberculosis activity of thiosemicarbazones].
    INGRAO F; BELLI N
    Lotta Tuberc; 1951; 21(5-6):282-7. PubMed ID: 14874566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.